The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 21, 2026
Snapshot (as of Oct 21, 2026): McKesson Corporation (MCK) pays a $3.28 annual dividend ($0.94 quarterly), yielding 0.37% at $1030.12/share. Next ex-dividend date 2026-09-01. 26 consecutive years of dividend growth (Dividend Aristocrat). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.37%
Annual Dividend: $3.28 per share
Payout Ratio: 8.8%
Ex-Dividend Date: 2026-09-01
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 33
McKesson Corporation is one of the largest pharmaceutical distributors in the United States, moving branded, generic, specialty, and biosimilar drugs to retail pharmacies, hospitals, and long-term care centers. The McKesson Corporation dividend currently yields 0.4%, with trailing twelve-month payments of $3.28 per share paid quarterly. The next ex-dividend date is September 1, 2026. MCK stock carries a beta of 0.298, making it one of the lower-volatility names in the healthcare sector, which suits investors who prioritize dividend growth over current income.
McKesson Corporation pays out 8.8% of earnings as dividends, a payout ratio classified as conservative (below 40%). That figure leaves substantial room to sustain and grow the dividend even if earnings face pressure, and MCK's role as a critical link in pharmaceutical distribution, connecting manufacturers to pharmacies, hospitals, and clinics, supports recurring demand for its services. The primary risk to McKesson Corporation dividend safety is concentration in pharmaceutical distribution, where pricing pressure or regulatory changes could compress margins over time.
McKesson Corporation dividend history shows a CAGR of 10.3% per year from 2011 to 2025. Per-share payments grew from $0.78 to $3.06 over that period (2026 data is partial and excluded from the growth calculation). The smallest annual increase in the window was 2.6% in 2012, while the largest reached 17.7% in 2018, showing the range of outcomes across the full history.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +14.8% | $2.02 (2022) | $3.06 (2025) |
| 5-Year | +13.0% | $1.66 (2020) | $3.06 (2025) |
| 10-Year | +11.4% | $1.04 (2015) | $3.06 (2025) |
MCK stock fits growth-and-income investors who want dividend expansion from a business embedded in essential pharmaceutical infrastructure, and who can accept a low current yield in exchange for that growth rate. At 0.4%, the yield is low (below 2%) and sits below the 5-year average of 0.47%, so current income is minimal. What MCK offers instead is 26 consecutive years of dividend increases, qualifying it as a Dividend Aristocrat, backed by a 10.3% annual growth rate over the past 14 years. The trade-off is straightforward: investors get a fast-growing dividend at a very low starting yield.
MCK is a Dividend Aristocrat with 26 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-01 | $0.9400 |
| 2026-06-01 | $0.8200 |
| 2026-03-02 | $0.8200 |
| 2025-12-01 | $0.8200 |
| 2025-09-02 | $0.8200 |
| 2025-06-02 | $0.7100 |
| 2025-03-03 | $0.7100 |
| 2024-12-02 | $0.7100 |
| 2024-08-30 | $0.7100 |
| 2024-06-03 | $0.6200 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.5800 |
| 2025 | $3.0600 |
| 2024 | $2.6600 |
| 2023 | $2.3200 |
| 2022 | $2.0200 |
Project income from MCK with the MCK dividend calculator or track your full portfolio with the dividend tracker.